Sequenom, Inc. (NASDAQ: SQNM) is focused on providing superior genetic analysis products designed to translate genomic science into advanced solutions for biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research, and possibly clinical utility. MassARRAY, the company’s high-performance DNA analysis platform, efficiently and precisely measures the amount of genetic target material as well as the variations within. For further information, visit the Company’s web site at www.sequenom.com.
- 17 years ago
QualityStocks
Sequenom, Inc. (NASDAQ: SQNM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Advances Integrated Approach in Broader Growth Strategy
Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF) recently took a significant step in fostering industry collaboration and…
-
MoneyShow Presents Real Estate Plays for Profit and Income Expo
MoneyShow has empowered individual investors and traders with state-of-the-art tools, education, and access to specific…
-
New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Eyes Bolivia’s Untapped Silver Potential Amid Global Supply Gaps
Bolivia, despite its rich mining history, remains one of the most underexplored silver jurisdictions due…